MetaCap

Who Owns Organogenesis Stock?

NASDAQ: ORGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.7716-0.0176 (-2.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
51.92%
Institutional holders
165
  • Institutions 51.9%
  • Insiders 44.2%
  • Public and other 3.9%

Who owns Organogenesis stock?

Institutional investors own about 51.9% of Organogenesis's shares, spread across 165 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 44.17% of ORGO.

The largest institutional holders are Morgan Stanley (9.08%), Soleus Capital Management, L.P. (8.71%) and Blackrock Inc. (5.96%). Together, the top 10 institutions control 36.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ORGO positions and 4 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of ORGO

Organogenesis top institutional holders
InstitutionShares% HeldChange
Morgan Stanley11.78M9.08%+0.5%
Soleus Capital Management, L.P.11.30M8.71%+11.4%
Blackrock Inc.7.74M5.96%+6.8%
Shaw D.E. & Co., Inc.3.13M2.41%+8.4%
Vanguard Capital Management LLC2.95M2.27%+1.4%
AQR Capital Management, LLC2.84M2.19%-5.8%
Dimensional Fund Advisors LP2.45M1.89%-19.7%
Acadian Asset Management. LLC1.97M1.52%+27.8%
Assenagon Asset Management S.A.1.95M1.51%-0.7%
Geode Capital Management, LLC1.84M1.41%-5.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of ORGO

Organogenesis top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.99M1.53%
iShares Trust-iShares Russell 2000 ETF1.81M1.40%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund842.14K0.65%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund654.82K0.50%
iShares Trust-iShares Russell 2000 Value ETF632.07K0.49%
Vanguard Explorer Fund492.50K0.38%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund395.25K0.30%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund356.71K0.27%
DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Targeted Value Portfolio356.42K0.27%
SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF347.53K0.27%

Frequently asked questions

Who is the largest shareholder of Organogenesis?

Morgan Stanley is the largest institutional shareholder of ORGO, owning 9.08% of shares outstanding (11.78M shares) as of its latest 13F filing.

What percentage of Organogenesis is owned by institutions?

Institutions own about 51.9% of ORGO shares and 93.0% of the public float.

How much of Organogenesis do insiders own?

Insiders, such as officers and directors, own about 44.17% of ORGO shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related